Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00449683
Status:
COMPLETED
Last Update Posted:
2016-08-25
First Post:
2007-03-19
Brief Title:
Excessive Sweating Caused by Antidepressants Measurement and Treatment With Terazosin
Sponsor:
Thomas Jefferson University
Organization:
Thomas Jefferson University
Study Overview
Official Title:
Antidepressant Induced Excessive Sweating Measurement and Treatment With Terazosin
Status:
COMPLETED
Status Verified Date:
2016-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ADIES
Brief Summary:
The study consists of measurement of antidepressant-induced excessive sweating and its treatment with an experimental medication terazosin approved for hypertension that will be added to the antidepressant This study is for people who take an antidepressant due to a depressive disorder This is an open-label study no placebo group that will last 5 weeks with one week of baseline measurement and four weeks of treatment with the study medication The study is based on the hypothesis that terazosin will be effective in reducing the severity of excessive sweating caused by antidepressant treatment and will have minimal side-effects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None